FDA Inspection 1266924 — Sourav K. Mishra, M.D.
The FDA completed an inspection of Sourav K. Mishra, M.D. on Mar 20, 2025 in Bhubaneswar. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Mar 20, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bhubaneswar (India)
Additional Details
Clinical BA/BE